Cartesian Therapeutics, Inc. RNAC Q1 2026 earnings

FAQ

When did Cartesian Therapeutics, Inc. report Q1 2026 earnings?

Cartesian Therapeutics, Inc. (RNAC) reported Q1 2026 earnings on April 30, 2026 before market open.

What were Cartesian Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Cartesian Therapeutics, Inc. reported revenue of $78.0K and eps of $-1.46 for Q1 2026.

Did Cartesian Therapeutics, Inc. beat estimates in Q1 2026?

Revenue missed the consensus estimate of $219.8K by $141.8K. EPS missed the consensus estimate of $-0.84 by $0.62.

How did Cartesian Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 92.9% from $1.1M a year earlier and eps declined 114.7% from $-0.68.

Where can I find Cartesian Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001453687-26-000081) and the 10-Q periodic report (0001453687-26-000082) directly on SEC EDGAR. The filing index links above go to sec.gov.